Last 12 months
Inside the activity.
8 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 8 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 10, 2022 Filed Feb 14, 2022 21:10 UTC |
MAIN ALAN JEVP, Innov & Chem Sciences
|
GrantStock Option (Right to Buy) · Derivative | 230,990 | $0.00 Strike: $3.20 | $0.00 |
DisclosureSEC source: 0001127602-22-004767 · form4.xml · derivative · entry 1 MAIN ALAN J · CIK 0001227372 · EVP, Innov & Chem Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 230,990 Underlying: Common Stock · 230,990 shares Expires 2032-02-10 F1 · derivative.exercise_date: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 21:08 UTC |
WADE JEFFREY LPresident and CFO
|
GrantRestricted Stock Units · Derivative | 111,820 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-004763 · form4.xml · derivative · entry 2 WADE JEFFREY L · CIK 0001225767 · President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,820 Underlying: Common Stock · 111,820 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F3 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 21:08 UTC |
WADE JEFFREY LPresident and CFO
|
GrantStock Option (Right to Buy) · Derivative | 335,470 | $0.00 Strike: $3.20 | $0.00 |
DisclosureSEC source: 0001127602-22-004763 · form4.xml · derivative · entry 1 WADE JEFFREY L · CIK 0001225767 · President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 335,470 Underlying: Common Stock · 335,470 shares Expires 2032-02-10 F1 · derivative.exercise_date: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 21:09 UTC |
Seth KiernanVP, Chief Commercial Officer
|
GrantRestricted Stock Units · Derivative | 68,890 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-004765 · form4.xml · derivative · entry 2 Seth Kiernan · CIK 0001890439 · VP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,890 Underlying: Common Stock · 68,890 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F3 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 21:09 UTC |
Seth KiernanVP, Chief Commercial Officer
|
GrantStock Option (Right to Buy) · Derivative | 206,670 | $0.00 Strike: $3.20 | $0.00 |
DisclosureSEC source: 0001127602-22-004765 · form4.xml · derivative · entry 1 Seth Kiernan · CIK 0001890439 · VP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 206,670 Underlying: Common Stock · 206,670 shares Expires 2032-02-10 F1 · derivative.exercise_date: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 21:06 UTC |
Kassler-Taub Kenneth B.SVP, Regulatory & QA
|
GrantRestricted Stock Units · Derivative | 82,670 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-004761 · form4.xml · derivative · entry 2 Kassler-Taub Kenneth B. · CIK 0001885219 · SVP, Regulatory & QA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,670 Underlying: Common Stock · 82,670 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F3 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 21:06 UTC |
Kassler-Taub Kenneth B.SVP, Regulatory & QA
|
GrantStock Option (Right to Buy) · Derivative | 248,010 | $0.00 Strike: $3.20 | $0.00 |
DisclosureSEC source: 0001127602-22-004761 · form4.xml · derivative · entry 1 Kassler-Taub Kenneth B. · CIK 0001885219 · SVP, Regulatory & QA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 248,010 Underlying: Common Stock · 248,010 shares Expires 2032-02-10 F1 · derivative.exercise_date: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 21:05 UTC |
COATS LONNELDirector · Chief Executive Officer
|
GrantRestricted Stock Units · Derivative | 274,090 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-004760 · form4.xml · derivative · entry 2 COATS LONNEL · CIK 0001612528 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 274,090 Underlying: Common Stock · 274,090 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F3 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 21:05 UTC |
COATS LONNELDirector · Chief Executive Officer
|
GrantStock Option (Right to Buy) · Derivative | 822,280 | $0.00 Strike: $3.20 | $0.00 |
DisclosureSEC source: 0001127602-22-004760 · form4.xml · derivative · entry 1 COATS LONNEL · CIK 0001612528 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 822,280 Underlying: Common Stock · 822,280 shares Expires 2032-02-10 F1 · derivative.exercise_date: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 21:04 UTC |
Granowitz Craig BSVP, Chief Medical Officer
|
GrantRestricted Stock Units · Derivative | 83,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-004759 · form4.xml · derivative · entry 2 Granowitz Craig B · CIK 0001876655 · SVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,750 Underlying: Common Stock · 83,750 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F3 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 21:04 UTC |
Granowitz Craig BSVP, Chief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 251,250 | $0.00 Strike: $3.20 | $0.00 |
DisclosureSEC source: 0001127602-22-004759 · form4.xml · derivative · entry 1 Granowitz Craig B · CIK 0001876655 · SVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 251,250 Underlying: Common Stock · 251,250 shares Expires 2032-02-10 F1 · derivative.exercise_date: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 21:02 UTC |
Alexander KristenVP, Finance and Accounting
|
GrantRestricted Stock Units · Derivative | 31,850 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-004757 · form4.xml · derivative · entry 2 Alexander Kristen · CIK 0001878867 · VP, Finance and Accounting 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,850 Underlying: Common Stock · 31,850 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F3 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 21:02 UTC |
Alexander KristenVP, Finance and Accounting
|
GrantStock Option (Right to Buy) · Derivative | 47,780 | $0.00 Strike: $3.20 | $0.00 |
DisclosureSEC source: 0001127602-22-004757 · form4.xml · derivative · entry 1 Alexander Kristen · CIK 0001878867 · VP, Finance and Accounting 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,780 Underlying: Common Stock · 47,780 shares Expires 2032-02-10 F1 · derivative.exercise_date: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 21:03 UTC |
Crum Brian TSVP, General Counsel & Secr.
|
GrantRestricted Stock Units · Derivative | 78,290 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-004758 · form4.xml · derivative · entry 2 Crum Brian T · CIK 0001792747 · SVP, General Counsel & Secr. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,290 Underlying: Common Stock · 78,290 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F3 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 21:03 UTC |
Crum Brian TSVP, General Counsel & Secr.
|
GrantStock Option (Right to Buy) · Derivative | 234,870 | $0.00 Strike: $3.20 | $0.00 |
DisclosureSEC source: 0001127602-22-004758 · form4.xml · derivative · entry 1 Crum Brian T · CIK 0001792747 · SVP, General Counsel & Secr. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 234,870 Underlying: Common Stock · 234,870 shares Expires 2032-02-10 F1 · derivative.exercise_date: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 02:34 UTC |
McDermott WendyVP, Human Resources
|
GrantStock Option (Right to Buy) · Derivative | 85,185 | $0.00 Strike: $3.94 | $0.00 |
DisclosureSEC source: 0001127602-22-000731 · form4.xml · derivative · entry 1 McDermott Wendy · CIK 0001902760 · VP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,185 Underlying: Common Stock · 85,185 shares Expires 2032-01-03 F1 · derivative.exercise_date: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant (1/3/2023) and vests 1/48th per month for each month of service thereafter. Read SEC document |
| August 02, 2021 Filed Aug 3, 2021 20:39 UTC |
Granowitz Craig BSVP, Chief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 250,000 | $0.00 Strike: $3.54 | $0.00 |
DisclosureSEC source: 0001127602-21-022954 · form4.xml · derivative · entry 1 Granowitz Craig B · CIK 0001876655 · SVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Stock · 250,000 shares Expires 2031-08-02 F1 · derivative.exercise_date: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant (8/2/2022) and vests 1/48th per month for each month of service thereafter. Read SEC document |
| July 01, 2021 Filed Jan 10, 2022 21:17 UTC |
SOBECKI CHRISTOPHER JDirector
|
GiftCommon Stock | 5,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-001242 · form5.xml · nonDerivative · entry 1 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,697 Read SEC document |
| April 30, 2021 Filed May 3, 2021 21:07 UTC |
SOBECKI CHRISTOPHER JDirector
|
GrantStock Option (Right to Buy) · Derivative | 6,475 | $0.00 Strike: $5.04 | $0.00 |
DisclosureSEC source: 0001127602-21-014973 · form4.xml · derivative · entry 2 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,475 Underlying: Common Stock · 6,475 shares Expires 2031-04-30 F3 · derivative.exercise_date: Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date. Read SEC document |
| April 30, 2021 Filed May 3, 2021 21:07 UTC |
SOBECKI CHRISTOPHER JDirector
|
GrantRestricted Stock Units · Derivative | 4,024 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-014973 · form4.xml · derivative · entry 1 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,024 Underlying: Common Stock · 4,024 shares Expires not disclosed F1 · derivative.exercise_date: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. F2 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| April 30, 2021 Filed May 3, 2021 21:06 UTC |
Swain Judith LDirector
|
GrantStock Option (Right to Buy) · Derivative | 6,475 | $0.00 Strike: $5.04 | $0.00 |
DisclosureSEC source: 0001127602-21-014971 · form4.xml · derivative · entry 2 Swain Judith L · CIK 0001413573 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,475 Underlying: Common Stock · 6,475 shares Expires 2031-04-30 F3 · derivative.exercise_date: Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date. Read SEC document |
| April 30, 2021 Filed May 3, 2021 21:06 UTC |
Swain Judith LDirector
|
GrantRestricted Stock Units · Derivative | 4,024 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-014971 · form4.xml · derivative · entry 1 Swain Judith L · CIK 0001413573 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,024 Underlying: Common Stock · 4,024 shares Expires not disclosed F1 · derivative.exercise_date: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. F2 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| April 30, 2021 Filed May 3, 2021 21:06 UTC |
Palantoni FrankDirector
|
GrantStock Option (Right to Buy) · Derivative | 6,475 | $0.00 Strike: $5.04 | $0.00 |
DisclosureSEC source: 0001127602-21-014968 · form4.xml · derivative · entry 2 Palantoni Frank · CIK 0001307963 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,475 Underlying: Common Stock · 6,475 shares Expires 2031-04-30 F3 · derivative.exercise_date: Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date. Read SEC document |
| April 30, 2021 Filed May 3, 2021 21:06 UTC |
Palantoni FrankDirector
|
GrantRestricted Stock Units · Derivative | 4,024 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-014968 · form4.xml · derivative · entry 1 Palantoni Frank · CIK 0001307963 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,024 Underlying: Common Stock · 4,024 shares Expires not disclosed F1 · derivative.exercise_date: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. F2 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| April 30, 2021 Filed May 3, 2021 21:05 UTC |
LEFKOWITZ ROBERT J MDDirector
|
GrantStock Option (Right to Buy) · Derivative | 6,475 | $0.00 Strike: $5.04 | $0.00 |
DisclosureSEC source: 0001127602-21-014967 · form4.xml · derivative · entry 2 LEFKOWITZ ROBERT J MD · CIK 0001226385 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,475 Underlying: Common Stock · 6,475 shares Expires 2031-04-30 F3 · derivative.exercise_date: Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date. Read SEC document |
| April 30, 2021 Filed May 3, 2021 21:05 UTC |
LEFKOWITZ ROBERT J MDDirector
|
GrantRestricted Stock Units · Derivative | 4,024 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-014967 · form4.xml · derivative · entry 1 LEFKOWITZ ROBERT J MD · CIK 0001226385 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,024 Underlying: Common Stock · 4,024 shares Expires not disclosed F1 · derivative.exercise_date: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. F2 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| April 30, 2021 Filed May 3, 2021 21:04 UTC |
NIES ALAN SDirector
|
GrantStock Option (Right to Buy) · Derivative | 6,475 | $0.00 Strike: $5.04 | $0.00 |
DisclosureSEC source: 0001127602-21-014965 · form4.xml · derivative · entry 2 NIES ALAN S · CIK 0001270260 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,475 Underlying: Common Stock · 6,475 shares Expires 2031-04-30 F3 · derivative.exercise_date: Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date. Read SEC document |
| April 30, 2021 Filed May 3, 2021 21:04 UTC |
NIES ALAN SDirector
|
GrantRestricted Stock Units · Derivative | 4,024 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-014965 · form4.xml · derivative · entry 1 NIES ALAN S · CIK 0001270260 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,024 Underlying: Common Stock · 4,024 shares Expires not disclosed F1 · derivative.exercise_date: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. F2 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| April 30, 2021 Filed May 3, 2021 21:03 UTC |
DEBBANE RAYMONDDirector
|
GrantStock Option (Right to Buy) · Derivative | 6,475 | $0.00 Strike: $5.04 | $0.00 |
DisclosureSEC source: 0001127602-21-014963 · form4.xml · derivative · entry 2 DEBBANE RAYMOND · CIK 0001053890 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,475 Underlying: Common Stock · 6,475 shares Expires 2031-04-30 F3 · derivative.exercise_date: Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date. Read SEC document |
| April 30, 2021 Filed May 3, 2021 21:03 UTC |
DEBBANE RAYMONDDirector
|
GrantRestricted Stock Units · Derivative | 4,024 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-014963 · form4.xml · derivative · entry 1 DEBBANE RAYMOND · CIK 0001053890 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,024 Underlying: Common Stock · 4,024 shares Expires not disclosed F1 · derivative.exercise_date: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. F2 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| April 30, 2021 Filed May 3, 2021 21:02 UTC |
BARKER SAM LDirector
|
GrantStock Option (Right to Buy) · Derivative | 6,475 | $0.00 Strike: $5.04 | $0.00 |
DisclosureSEC source: 0001127602-21-014962 · form4.xml · derivative · entry 2 BARKER SAM L · CIK 0001226877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,475 Underlying: Common Stock · 6,475 shares Expires 2031-04-30 F3 · derivative.exercise_date: Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date. Read SEC document |
| April 30, 2021 Filed May 3, 2021 21:02 UTC |
BARKER SAM LDirector
|
GrantRestricted Stock Units · Derivative | 4,024 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-014962 · form4.xml · derivative · entry 1 BARKER SAM L · CIK 0001226877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,024 Underlying: Common Stock · 4,024 shares Expires not disclosed F1 · derivative.exercise_date: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. F2 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| April 30, 2021 Filed May 3, 2021 21:02 UTC |
Amouyal PhilippeDirector
|
GrantStock Option (Right to Buy) · Derivative | 6,475 | $0.00 Strike: $5.04 | $0.00 |
DisclosureSEC source: 0001127602-21-014960 · form4.xml · derivative · entry 2 Amouyal Philippe · CIK 0001376854 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,475 Underlying: Common Stock · 6,475 shares Expires 2031-04-30 F3 · derivative.exercise_date: Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date. Read SEC document |
| April 30, 2021 Filed May 3, 2021 21:02 UTC |
Amouyal PhilippeDirector
|
GrantRestricted Stock Units · Derivative | 4,024 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-014960 · form4.xml · derivative · entry 1 Amouyal Philippe · CIK 0001376854 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,024 Underlying: Common Stock · 4,024 shares Expires not disclosed F1 · derivative.exercise_date: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. F2 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| April 24, 2021 Filed Apr 27, 2021 20:51 UTC |
Swain Judith LDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 10,638 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-014524 · form4.xml · derivative · entry 2 Swain Judith L · CIK 0001413573 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,638 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. F2 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| April 24, 2021 Filed Apr 27, 2021 20:51 UTC |
Swain Judith LDirector
|
Exercise / conversionCommon Stock | 10,638 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-014524 · form4.xml · nonDerivative · entry 1 Swain Judith L · CIK 0001413573 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,006 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 24, 2021 Filed Apr 27, 2021 20:50 UTC |
SOBECKI CHRISTOPHER JDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 10,638 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-014523 · form4.xml · derivative · entry 2 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,638 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. F2 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| April 24, 2021 Filed Apr 27, 2021 20:50 UTC |
SOBECKI CHRISTOPHER JDirector
|
Exercise / conversionCommon Stock | 10,638 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-014523 · form4.xml · nonDerivative · entry 1 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,397 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 24, 2021 Filed Apr 27, 2021 20:49 UTC |
Palantoni FrankDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 10,638 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-014522 · form4.xml · derivative · entry 2 Palantoni Frank · CIK 0001307963 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,638 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. F2 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| April 24, 2021 Filed Apr 27, 2021 20:49 UTC |
Palantoni FrankDirector
|
Exercise / conversionCommon Stock | 10,638 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-014522 · form4.xml · nonDerivative · entry 1 Palantoni Frank · CIK 0001307963 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,006 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 24, 2021 Filed Apr 27, 2021 20:48 UTC |
LEFKOWITZ ROBERT J MDDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 10,638 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-014520 · form4.xml · derivative · entry 2 LEFKOWITZ ROBERT J MD · CIK 0001226385 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,638 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. F2 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| April 24, 2021 Filed Apr 27, 2021 20:48 UTC |
LEFKOWITZ ROBERT J MDDirector
|
Exercise / conversionCommon Stock | 10,638 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-014520 · form4.xml · nonDerivative · entry 1 LEFKOWITZ ROBERT J MD · CIK 0001226385 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,006 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 24, 2021 Filed Apr 27, 2021 20:48 UTC |
NIES ALAN SDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 10,638 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-014521 · form4.xml · derivative · entry 2 NIES ALAN S · CIK 0001270260 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,638 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. F2 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| April 24, 2021 Filed Apr 27, 2021 20:48 UTC |
NIES ALAN SDirector
|
Exercise / conversionCommon Stock | 10,638 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-014521 · form4.xml · nonDerivative · entry 1 NIES ALAN S · CIK 0001270260 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,720 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 24, 2021 Filed Apr 27, 2021 20:47 UTC |
DEBBANE RAYMONDDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 10,638 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-014519 · form4.xml · derivative · entry 3 DEBBANE RAYMOND · CIK 0001053890 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,638 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. F2 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| April 24, 2021 Filed Apr 27, 2021 20:47 UTC |
DEBBANE RAYMONDDirector
|
Exercise / conversionCommon Stock | 10,638 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-014519 · form4.xml · nonDerivative · entry 1 DEBBANE RAYMOND · CIK 0001053890 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 327,521 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 24, 2021 Filed Apr 27, 2021 20:46 UTC |
BARKER SAM LDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 10,638 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-014518 · form4.xml · derivative · entry 2 BARKER SAM L · CIK 0001226877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,638 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. F2 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| April 24, 2021 Filed Apr 27, 2021 20:46 UTC |
BARKER SAM LDirector
|
Exercise / conversionCommon Stock | 10,638 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-014518 · form4.xml · nonDerivative · entry 1 BARKER SAM L · CIK 0001226877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,291 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 24, 2021 Filed Apr 27, 2021 20:45 UTC |
Amouyal PhilippeDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 10,638 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-014517 · form4.xml · derivative · entry 2 Amouyal Philippe · CIK 0001376854 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,638 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. F2 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| April 24, 2021 Filed Apr 27, 2021 20:45 UTC |
Amouyal PhilippeDirector
|
Exercise / conversionCommon Stock | 10,638 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-014517 · form4.xml · nonDerivative · entry 1 Amouyal Philippe · CIK 0001376854 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,006 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.